• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, January 21, 2026
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Vision Eye Institute appoints Amanda Cranage to replace James Thiedeman as CEO

by rhiannon bowman
June 20, 2023
in Local, News
Reading Time: 3 mins read
A A
Ms Amanda Cranage, a long-standing member of the organisation, has been appointed CEO, effective immediately.

Ms Amanda Cranage, a long-standing member of the organisation, has been appointed CEO, effective immediately.

Share on FacebookShare on Twitter

Vision Eye Institute (VEI) has announced a change in its leadership with CEO Mr James Thiedeman stepping down after more than five and a half years at the helm.

It has appointed Ms Amanda Cranage, a long-standing member of the organisation, to the CEO role, effective immediately. Thiedeman’s departure marks the end of a transformative era for VEI, the organisation said.

“Under his guidance, the company has achieved remarkable growth, expanded its market reach and solidified its position as a leading player in the industry – despite the challenges of a global pandemic, increased healthcare costs and workforce shortages.”

Thiedeman said it had been a privilege leading an organisation that transforms the lives of patients every day.

VEI is Australia’s largest private ophthalmology provider and operates eleven day surgeries through Vision Hospital Group.

James Thiedeman served five and a half years as CEO of Vision Eye Institute.

“VEI extends its deepest gratitude to James for his exceptional leadership, dedication, and countless contributions to the organisation’s success. In this time of transition, VEI remains steadfast in its commitment to continuous delivery of exceptional patient care,” the organisation said.

“With that commitment in mind, we welcome Amanda Cranage, a respected and accomplished leader, to her new role. Having served VEI for several years in various pivotal positions, Amanda possesses a profound understanding of the organisation’s core values, culture and strategic direction.”

VEI said that throughout her tenure at VEI, Cranage has consistently demonstrated exceptional leadership skills, innovative thinking and an unwavering commitment to the core mission of the organisation: the delivery of exceptional patient care.

“Her extensive industry knowledge, combined with a deep understanding of customer needs, positions her perfectly to steer VEI toward continued success and growth,” the organisation said.

With more than 30 years’ experience in both the public and private healthcare sectors, Cranage brings a wealth of knowledge and expertise as the new CEO and managing director of Vision Eye Institute and Vision Hospital Group.

Beginning her career as an orthoptist, she transitioned to operational management more than 16 years ago, marking the start of her leadership journey.

Previously responsible for driving and growing the Victorian and Brisbane businesses, Cranage successfully led the development of Panch Day Surgery in Melbourne, a major refurbishment of RiverCity Private Hospital (Level 3) in Brisbane, and the extensive expansion and refurbishment of Vision Eye Institute’s Footscray consulting facility in Melbourne.

She has also held the nationwide responsibility for health fund negotiations for Vision Hospital Group and executive responsibility for the national projects portfolio.

“I am thrilled by the opportunity to lead this exceptional team and drive our organisation towards new heights of success,” Cranage said.

“As I move into the role of CEO, I am committed to upholding the values and principles that have been the foundation of VEI’s success.”

Cranage is also chair of the board of directors of Alina Vision, a social enterprise that aims to address the rising demand for eye health services in the world’s most underserved communities.

More reading

New leaders and expanded services mark year of achievements for Vision Eye Institute

Vision Eye Institute – a vision realised

New national medical director at Vision Eye Institute

Related Posts

The implant combines lab-grown human embryonic stem cell-derived RPE cells with an ultrathin synthetic parylene scaffold. Image: catalin/stock.adobe.com

Stem-cell retinal implant shows promise in dry AMD

by Staff Writer
January 21, 2026

Researchers in the United States are advancing a groundbreaking stem-cell retinal implant for people with advanced dry age-related macular degeneration...

There are plenty of pathways to help optometrists and dispensers into practice ownership. Image: Fxquadro/stock.adobe.com.

Webinar to help dispensers, optometrists into ownership

by Staff Writer
January 21, 2026

Optical Dispensers Australia (ODA), Eyecare Plus, ProVision, Vision Connection and Eyebenefit are working together to guide entrepreneurs and open the...

The glasses have a number of microphones built into the frames. Image: Nuance Audio.

Research evaluates Nuance Audio glasses in lab, real world

by Staff Writer
January 20, 2026

EssilorLuxottica has announced new clinical findings from two studies, including one in Australia, evaluating the performance of Nuance Audio glasses,...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2026 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited